NDC 71511-503
Nexiclon XR
Clonidine
Nexiclon XR is a Oral Tablet, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Athena Bioscience, Llc. The primary component is Clonidine.
| Product ID | 71511-503_dad34ef3-06d2-6355-e053-2995a90aee5f |
| NDC | 71511-503 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Nexiclon XR |
| Generic Name | Clonidine |
| Dosage Form | Tablet, Extended Release |
| Route of Administration | ORAL |
| Marketing Start Date | 2022-03-01 |
| Marketing Category | NDA / |
| Application Number | NDA022500 |
| Labeler Name | Athena Bioscience, LLC |
| Substance Name | CLONIDINE |
| Active Ingredient Strength | 0 mg/1 |
| Pharm Classes | Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |